The market of antiviral drugs is segmented on the basis of products, such as Hepatitis-C antivirals, HIV antivirals, Herpes antivirals, Hepatitis-B antivirals, Influenza antivirals and others. The market is also segmented on the basis of enzyme specific actions, such as DNA polymerase inhibitors, NS3 Protease inhibitors, reverse transcriptase inhibitors and others. The market is also segmented on the basis of geography, such as North America, Europe, Asia-Pacific and Rest of the World (RoW). The U.S. is the biggest market for antiviral drugs, followed by the U.K. and Japan. However, Asia-Pacific and African regions of the world are considered as the most promising markets in the forecast period. Virus is a micro-infectious agent that replicates only in the living cells,which results in prevalence of disease. Antiviral drugs are a class of medications that are specifically used to treat the viral infections. Usually, antivirals inhibit the growth of pathogens.

Browse Full Report : http://www.transparencymarketresearch.com/antivirals-market.html

Some of the key factors driving the antiviral drugs market are strong R&D activities, increase in healthcare expenditure, increased prevalence of the life-threatening viral diseases and increase in the public awareness. According to WHO, as of October 2013, there are around 35.3 million people in the world, infected with HIV. Hence, increased viral infection incidences is one of the prominent factors that drives the market growth. Due to strong R&D activities, newer and advanced formulations and treatments, such as combination therapy, vaccines and others, are being introduced in the market. Thus, strong R&D is one of the key factors in the market growth. On the other hand, high cost of R&D and therapy, high risk of failure and government austerity are some of threats expected to hinder the growth of market.

Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2306

Some of the major players operating in this market includes GlaxoSmithKline, plc. Abbott Laboratories, AstraZeneca AB, BoehringerIngelheim Corporation, Novartis International AG, Merck and Co. Inc., Johnson & Johnson amongst others.

Contact us:

Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email:Â [email protected]
Website: http://www.transparencymarketresearch.com/